Valneva SE (VALN) Assets (2020 - 2026)
Valneva SE (VALN) posted quarterly Assets of $423.3 million for Q1 2026, down 22.86% year-on-year from $548.8 million in Q1 2025, and down 6.73% on a QoQ basis from $453.9 million in Q4 2025.
Valneva SE (VALN) Assets (2020 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Assets for 7 consecutive years, with $423.3 million the latest figure, recorded in Q1 2026.
- Quarterly Assets fell 22.86% year-over-year to $423.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $423.3 million (down 22.86% YoY) and the FY2025 annual result came in at $453.9 million, down 20.24% from the prior year.
- Assets declined to $423.3 million in Q1 2026 per VALN's latest filing, from $453.9 million in the prior quarter.
- Over the last five years, Assets for VALN reached as high as $885.0 million in Q1 2022 and fell as low as $423.3 million in Q1 2026.
- A 5-year average of $608.8 million and a median of $572.2 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets retreated 25.96% — and 2024, when it gained 8.69%.
- Year by year, Assets stood at $707.1 million in 2022, then fell by 25.96% to $523.5 million in 2023, then increased by 8.69% to $569.0 million in 2024, then retreated by 20.24% to $453.9 million in 2025, then declined by 6.73% to $423.3 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $423.3 million, $453.9 million, and $510.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | 423.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 423.33 Mn |
| Dec 31, 2025 | 453.86 Mn |
| Sep 30, 2025 | 510.06 Mn |
| Jun 30, 2025 | 537.83 Mn |
| Mar 31, 2025 | 548.77 Mn |
| Dec 31, 2024 | 569.01 Mn |
| Sep 30, 2024 | 587.88 Mn |
| Jun 30, 2024 | 530.93 Mn |
| Mar 31, 2024 | 572.20 Mn |
| Dec 31, 2023 | 523.53 Mn |
| Sep 30, 2023 | 592.35 Mn |
| Jun 30, 2023 | 617.42 Mn |
| Mar 31, 2023 | 671.39 Mn |
| Dec 31, 2022 | 707.06 Mn |
| Sep 30, 2022 | 794.39 Mn |
| Jun 30, 2022 | 825.14 Mn |
| Mar 31, 2022 | 885.00 Mn |
| Dec 31, 2021 | 930.11 Mn |
| Dec 31, 2020 | 511.13 Mn |